TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation

Dominik Wieland, Janine Kemming, Anita Schuch, Florian Emmerich, Percy A. Knolle, Christoph Neumann‐Haefelin, Werner Held, Dietmar Zehn, Maike Hofmann, Robert Thimme

Nature Communications · 2017 · 207 citations · 48 references

DOIFull text

Open access

Concepts

Abstract

Abstract Differentiation and fate of virus-specific CD8 + T cells after cessation of chronic antigen stimulation is unclear. Here we show that a TCF1 + CD127 + PD1 + hepatitis C virus (HCV)-specific CD8 + T-cell subset exists in chronically infected patients with phenotypic features of T-cell exhaustion and memory, both before and after treatment with direct acting antiviral (DAA) agents. This subset is maintained during, and for a long duration after, HCV elimination. After antigen re-challenge the less differentiated TCF1 + CD127 + PD1 + population expands, which is accompanied by emergence of terminally exhausted TCF1-CD127-PD1 hi HCV-specific CD8 + T cells. These results suggest the TCF1 + CD127 + PD1 + HCV-specific CD8 + T-cell subset has memory-like characteristics, including antigen-independent survival and recall proliferation. We thus provide evidence for the establishment of memory-like virus-specific CD8 + T cells in a clinically relevant setting of chronic viral infection and we uncover their fate after cessation of chronic antigen stimulation, implicating a potential strategy for antiviral immunotherapy.

References

48